182 related articles for article (PubMed ID: 2889081)
1. Placebo-controlled trial of recombinant alpha 2-interferon in Chinese HBsAg-carrier children.
Lai CL; Lok AS; Lin HJ; Wu PC; Yeoh EK; Yeung CY
Lancet; 1987 Oct; 2(8564):877-80. PubMed ID: 2889081
[TBL] [Abstract][Full Text] [Related]
2. Prolonged (6 months) treatment of chronic hepatitis B virus infection with recombinant leukocyte A interferon.
Carreño V; Porres JC; Mora I; Bartolomé J; Bas C; Gutiez J; Cortés J; Hernández Guio C
Liver; 1987 Dec; 7(6):325-32. PubMed ID: 3437794
[TBL] [Abstract][Full Text] [Related]
3. Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children.
Lai CL; Lin HJ; Lau JN; Flok AS; Wu PC; Chung HT; Wong LK; Leung MP; Yeung CY
Q J Med; 1991 Feb; 78(286):155-63. PubMed ID: 2031078
[TBL] [Abstract][Full Text] [Related]
4. Changes of hepatitis B virus (HBV) markers during prolonged recombinant interferon alpha-2A treatment of chronic HBV infection.
Mora I; Porres JC; Bartolomé J; Quiroga JA; Gutiez J; Hernández Guio C; Bas C; Carreño V
J Hepatol; 1987 Feb; 4(1):29-36. PubMed ID: 3571931
[TBL] [Abstract][Full Text] [Related]
5. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant.
Tchervenkov JI; Tector AJ; Barkun JS; Sherker A; Forbes CD; Elias N; Cantarovich M; Cleland P; Metrakos P; Meakins JL
Ann Surg; 1997 Sep; 226(3):356-65; discussion 365-8. PubMed ID: 9339942
[TBL] [Abstract][Full Text] [Related]
6. Recombinant leukocyte interferon treatment of chronic hepatitis B.
Dusheiko G; Dibisceglie A; Bowyer S; Sachs E; Ritchie M; Schoub B; Kew M
Hepatology; 1985; 5(4):556-60. PubMed ID: 4018728
[TBL] [Abstract][Full Text] [Related]
7. A controlled trial of recombinant interferon-alpha in Caucasian children with chronic hepatitis B.
Ruiz Moreno M; Jimenez J; Porres JC; Bartolomé J; Moreno A; Carreño V
Digestion; 1990; 45(1):26-33. PubMed ID: 2187723
[TBL] [Abstract][Full Text] [Related]
8. Randomised controlled trial of recombinant human interferon -alpha A for chronic active hepatitis B.
Williams SJ; Craig PI; Cooksley WG; Bye WA; Bilous M; Grierson JM; Nightingale BN; Burnett L; Hensley WJ; Batey RG
Aust N Z J Med; 1990 Feb; 20(1):9-19. PubMed ID: 2181991
[TBL] [Abstract][Full Text] [Related]
9. Long-term remission of chronic hepatitis B after alpha-interferon therapy.
Korenman J; Baker B; Waggoner J; Everhart JE; Di Bisceglie AM; Hoofnagle JH
Ann Intern Med; 1991 Apr; 114(8):629-34. PubMed ID: 2003708
[TBL] [Abstract][Full Text] [Related]
10. Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotype.
Sonneveld MJ; Rijckborst V; Cakaloglu Y; Simon K; Heathcote EJ; Tabak F; Mach T; Boucher CA; Hansen BE; Zeuzem S; Janssen HL
Antivir Ther; 2012; 17(1):9-17. PubMed ID: 22267464
[TBL] [Abstract][Full Text] [Related]
11. Prospective trial of recombinant leucocyte interferon in chronic hepatitis B: a 10-month follow-up study.
Coppens JP; Cornu C; Lens E; Lamy M; Geubel A
Liver; 1989 Oct; 9(5):307-13. PubMed ID: 2685491
[TBL] [Abstract][Full Text] [Related]
12. A randomised controlled trial of recombinant interferon-gamma in Chinese patients with chronic hepatitis B virus infection.
Lau JY; Lai CL; Wu PC; Chung HT; Lok AS; Lin HJ
J Med Virol; 1991 Jul; 34(3):184-7. PubMed ID: 1919540
[TBL] [Abstract][Full Text] [Related]
13. [Effect of interferon-alpha treatment in children with hepatitis B e antigen-positive chronic hepatitis B virus infection: a meta-analysis of follow-up for six months to two years].
Lin ZQ; Fang F; Guo ZF; Chen Q
Zhonghua Er Ke Za Zhi; 2007 Aug; 45(8):592-8. PubMed ID: 18021533
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B surface antigen/IgM complexes: relation to receptors for polymerized human serum albumin, hepatitis B virus (HBV) DNA polymerase activity and HBV markers.
Mora I; Carreño V; Porres JC; Gutiez J; Guio CH
Acta Virol; 1987 Mar; 31(2):116-25. PubMed ID: 2886020
[TBL] [Abstract][Full Text] [Related]
15. Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial.
Perrillo RP; Regenstein FG; Peters MG; DeSchryver-Kecskemeti K; Bodicky CJ; Campbell CR; Kuhns MC
Ann Intern Med; 1988 Jul; 109(2):95-100. PubMed ID: 3289433
[TBL] [Abstract][Full Text] [Related]
16. Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response.
Brook MG; McDonald JA; Karayiannis P; Caruso L; Forster G; Harris JR; Thomas HC
Gut; 1989 Aug; 30(8):1116-22. PubMed ID: 2670693
[TBL] [Abstract][Full Text] [Related]
17. A controlled study of treatment with recombinant interferon alpha in chronic hepatitis B virus infection: induction and maintenance schedules.
Carreño V; Porres JC; Mora I; Gutiez J; Quiroga JA; Ramón y Cajal S; Oliva H; Compernolle C; Bartolomé J
Antiviral Res; 1987 Oct; 8(3):125-37. PubMed ID: 3501274
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of hepatitis B viral DNA by solution hybridization: comparison with DNA polymerase and hepatitis B e antigen during antiviral therapy.
Kuhns MC; McNamara AL; Perrillo RP; Cabal CM; Campbel CR
J Med Virol; 1989 Apr; 27(4):274-81. PubMed ID: 2656908
[TBL] [Abstract][Full Text] [Related]
19. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
[TBL] [Abstract][Full Text] [Related]
20. Interferon therapy of chronic hepatitis B virus infection in Chinese.
Lok AS; Lai CL; Wu PC
J Hepatol; 1986; 3 Suppl 2():S209-15. PubMed ID: 3036936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
